Other grades of this product :
| LY 2784544 Basic information |
| Product Name: | LY 2784544 | | Synonyms: | LY 2784544;3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine;3-(4-chloro-2-fluorobenzyl)-2-Methyl-N-(3-Methyl-1H-pyrazol-5-yl)-8-(MorpholinoMethyl)iMidazo[1,2-b]pyridazin-6-aMine;LY2784544/LY-2784544;IMidazo[1,2-b]pyridazin-6-aMine, 3-[(4-chloro-2-fluorophenyl)Methyl]-2-Methyl-N-(5-Methyl-1H-pyrazol-3-yl)-8-(4-MorpholinylMethyl)-;LY2874544;CS-13;Gandotinib (LY2784544) | | CAS: | 1229236-86-5 | | MF: | C23H25ClFN7O | | MW: | 469.94 | | EINECS: | | Product Categories: | Inhibitors;JAK;Inhibitor;JAK/STAT;STAT | | Mol File: | 1229236-86-5.mol |
| LY 2784544 Chemical Properties |
| density | 1.45 | | solubility | ≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic | | form | solid | | pka | 14.12±0.10(Predicted) |
| LY 2784544 Usage And Synthesis |
| Uses | LY2784544 is a JAK2 inhibitor. LY2784544 may be used as a potential treatment for patients with myeloproliferative neoplasm. |
| LY 2784544 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye